BioLife Solns Analyst Ratings
BioLife Solutions: Strong Buy Rating on Robust Gross Margins and Positive Long-Term EBITDA Outlook
BioLife Solutions (BLFS) Receives a Buy From Craig-Hallum
Analysts Are Bullish on Top Healthcare Stocks: Fortress Biotech (FBIO), BioLife Solutions (BLFS)
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and BioLife Solutions (BLFS)
BioLife Solns Analyst Ratings
Benchmark Upgrades BioLife Solutions to Buy From Hold With $25 Price Target
Lake Street Reaffirms Their Buy Rating on BioLife Solutions (BLFS)
Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Xenon (XENE) and BioLife Solutions (BLFS)
BioLife Solutions (BLFS) Receives a Buy From Craig-Hallum
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Intra-Cellular Therapies (ITCI)
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Alimera (ALIM)
BioLife Solutions (BLFS) Receives a Buy From Lake Street
Buy Rating on BioLife Solutions: Focused Growth and Market Leadership Post-Divestiture
BioLife Solns Analyst Ratings
BioLife Solutions (BLFS) Receives a Buy From Northland Securities
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), BioLife Solutions (BLFS) and Inotiv (NOTV)
Analysts' Opinions Are Mixed on These Healthcare Stocks: BioLife Solutions (BLFS), Cooper Co (COO) and PTC Therapeutics (PTCT)
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Chimerix (CMRX)
BioLife Solutions (BLFS) Receives a Buy From Craig-Hallum